VNDA

Vanda Pharmaceuticals Inc

Jun 23 • 04:00PM ET

5.95

-0.05 -0.83 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NKTR KROS VKTX BMRN INCY RYTM AXSM MDGL KRYS NBIX

| Held by: XBI VTI IWM VXF IWN IBB VTWO SCHA VFMO DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.05	Insider Own	5.43%	Shs Outstand	60.14M	Perf Week	1.19%
Market Cap	357.81M	Forward P/E	-	EPS next Y	-0.76	Insider Trans	-9.54%	Shs Float	56.87M	Perf Month	-4.19%
Enterprise Value	168.57M	PEG	-	EPS next Q	-0.58	Inst Own	77.42%	Short Float	11.98%	Perf Quarter	-15.00%
Income	-239.55M	P/S	1.64	EPS this Y	39.77%	Inst Trans	6.85%	Short Ratio	6.31	Perf Half Y	-10.79%
Sales	217.78M	P/B	1.27	EPS next Y	66.15%	ROA	-44.97%	Short Interest	6.81M	Perf YTD	-32.54%
Book/sh	4.67	P/C	1.77	EPS next 5Y	45.07%	ROE	-60.48%	52W High	9.94 -40.14%	Perf Year	33.11%
Cash/sh	3.36	P/FCF	-	EPS past 3/5Y	- -	ROIC	-83.23%	52W Low	4.14 43.72%	Perf 3Y	-8.74%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-5.29% -2.73%	Gross Margin	89.91%	Volatility	4.90% 4.20%	Perf 5Y	-68.52%
Dividend TTM	-	EV/Sales	0.77	EPS Y/Y TTM	-434.76%	Oper. Margin	-73.64%	ATR (14)	0.28	Perf 10Y	-47.58%
Dividend Ex-Date	-	Quick Ratio	2.15	Sales Y/Y TTM	8.16%	Profit Margin	-109.99%	RSI (14)	44.24	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-62.10%	SMA20	-2.47%	Beta	0.61	Target Price	14.12
Payout	-	Debt/Eq	0.05	Sales Q/Q	3.35%	SMA50	-8.36%	Rel Volume	0.52	Prev Close	6.00
Employees	533	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-7.13%	Avg Volume	1.08M	Price	5.95
IPO	Apr 12, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	-19.19% -5.93%	Trades		Volume	584,860	Change	-0.83%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)